Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001808968-25-000003

CHIEF EXECUTIVE OFFICER sold 3,428 shares at $79.07 ($271,052)

  • CHIEF EXECUTIVE OFFICER acquired 15,625 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Grant or award : show line 1 in the form 10b5-1 +15,625 353,392 D
2025-12-02 Sale : show line 2 in the form 10b5-1 −3,428 $79.07 $271,052 349,964 D
Open-market sales · 3,428 sh · avg $79.07 · $271,052
Loading xslF345X05/form4-12032025_051202.xml…